Why the Mounjaro Price Increase Happened — and What It Means for UK Patients

What Eli Lilly's September 2025 decision actually changed

Mounjaro's UK pricing structure shifted significantly from 1 September 2025 when Eli Lilly revised its list prices across the dose range. The highest-strength pen rose from roughly £122 to around £330 per monthly supply, a figure that became widely cited in UK health reporting. That is the list price, the baseline from which private pharmacies build their own charges. Whether a provider passes that increase on in full, absorbs part of it, or adds their own margin on top will vary; the prices patients see at checkout reflect all of those layers combined.

The reason Lilly gave, in broad terms, was bringing UK pricing closer to the commercial realities of the market, Mounjaro had been priced below comparable international levels. Tirzepatide, the active ingredient, is the only dual GIP and GLP-1 receptor agonist licensed for weight management in the UK, as the NHS medicines page for tirzepatide outlines. That unique mechanism, and the investment behind it, is part of the pricing backdrop. Whether the increase was proportionate is a separate question, but knowing it originated with the manufacturer, not with individual pharmacies, is the starting point for understanding it.

For anyone watching the numbers closely, a fuller breakdown of what changed across the dose range from September 2025 covers the specifics by strength.

Why headline prices often tell only half the story

Private Mounjaro prices are quoted per pen, per month, or occasionally per course, and not every quote covers the same things. A figure that looks competitive can exclude the initial consultation fee, the prescription charge, delivery, and any follow-up clinical support. Add those back in and the comparison shifts considerably. This is not unique to weight-loss medicines; it reflects how private healthcare pricing generally works.

NICE's appraisal of tirzepatide, published as TA1026 in December 2024, confirmed Mounjaro's clinical value for eligible adults, but private pricing has no regulator setting a ceiling. That means the range between providers is real and sometimes substantial. What matters is knowing precisely what a given price includes before you sign up. Questions worth asking: Is the consultation free or charged? Is prescriber support available between doses? Is delivery included and tracked? Is there any clinical review before a repeat supply?

For context on how the 2.5mg starting dose is priced relative to higher strengths, the 2.5mg price increase page looks at that specific dose in detail. If you want a broader picture of what Mounjaro currently costs across the full dose range, that page brings together the current figures in one place. And for patients who are wondering whether their provider has held the line, there is guidance on which UK suppliers have not raised their Mounjaro prices following the September change.

What nume's pricing covers, and why we're not competing on cost alone

At nume, we're transparent about this: we are not the cheapest option in the UK market. That is a deliberate choice. One price covers your free consultation, the prescription, the treatment itself, and free next-working-day delivery via DPD in plain unbranded packaging. There are no bolt-on charges for aftercare, no subscription you forget to cancel, and no fee if a prescriber asks a question before approving a dose increase.

Our GPhC-registered pharmacy (registration number 9012878, verifiable on the GPhC register) sources Mounjaro through the licensed UK supply chain with an authorised Eli Lilly supplier relationship. Every consultation is read by a named prescriber the same day, if you order before 12pm Monday to Friday and are approved, your treatment leaves that day. That cut-off matters for practical planning: ordering on a Monday morning means your pen can arrive Tuesday, which works well around busy weeks, paydays, or ahead of a holiday when timing genuinely counts.

The price you see on our treatment page is the price you pay. No add-ons surface at checkout. More about how we operate is on our about page if you want to look under the bonnet before deciding.

Why searching for the cheapest Mounjaro is the wrong question

After a significant list-price increase, the instinct to find the lowest possible number is understandable. But for a prescription-only medicine, the cheapest listing rarely answers the question that actually matters: is this supply genuine, clinically supervised, and safe?

The MHRA has warned publicly and repeatedly about fake weight-loss pens sold through unverified online sellers and social media. In October 2025, enforcement teams raided the first illicit UK manufacturing site producing counterfeit tirzepatide pens, seizing approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million. Suspect sellers can be reported directly to the MHRA via the Yellow Card scheme. Prices far below the going market rate, sellers offering medicines without a prescription, and unfamiliar websites with no GPhC registration are all red flags that should prompt caution rather than a click.

A small saving against a regulated pharmacy is not worth the risk of receiving a counterfeit pen. The correct measure for a prescription medicine is whether supply is genuine, whether a real prescriber has assessed your suitability, and whether clinical support is available if something changes. If you want to understand how the 5mg dose price increase has affected patients mid-titration, that page looks at the specifics for that strength. If you want to understand how the cost increase affects ongoing treatment, that page looks at what repeat patients are experiencing. And if you're ready to talk to a prescriber about your options, starting a free consultation is the right next step.